- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diabetes Mellitus Type 2 in South Africa
Total 1014 results
-
SanofiHanmi Pharmaceutical Company LimitedTerminatedType 2 Diabetes MellitusEstonia, Spain, Ukraine, Italy, Germany, Canada, Mexico, United States, Argentina, Bulgaria, Chile, Denmark, Finland, Hungary, India, Korea, Republic of, Latvia, Lithuania, Norway, Peru, Poland, Romania, Russian Federation, Serbia, Slov... and more
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, France, Switzerland, Germany, South Africa, Korea, Republic of, Puerto Rico, Canada, Taiwan, Spain, Poland, Slovakia, Thailand, Mexico, Turkey, Australia, Greece, Norway, Sweden, Peru, Romania, Argentina, United Kingdom
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Spain, Canada
-
AstraZenecaEli Lilly and CompanyCompleted
-
Bristol-Myers SquibbMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusUnited States, Argentina, Canada, Mexico, Peru, Taiwan, Australia, Philippines, Thailand, Brazil, Chile, India, Russian Federation, Ukraine
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, Estonia, Latvia, Mexico
-
AstraZenecaCompletedType 2 Diabetes MellitusBrazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, South Africa, Spain, Turkey, China, Netherlands, Argentina, Austria, Czechia, United Arab Emirates, Taiwan, India, Egypt, Saudi Arabia, Lebanon, Indonesia, Col... and more
-
Response PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Eli Lilly and CompanyAlkermes, Inc.CompletedDiabetes Mellitus, Type 2United States, Argentina, Portugal, South Africa
-
TakedaCompletedType 2 Diabetes MellitusUnited States, Australia, Brazil, Bulgaria, Chile, Croatia, Estonia, Guatemala, India, Israel, Latvia, Mexico, New Zealand, Peru, Romania, Russian Federation, Serbia, South Africa, Ukraine
-
University of LiverpoolAstraZeneca; Clinical Practice Research DatalinkActive, not recruitingType 2 Diabetes MellitusUnited Kingdom
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusRussian Federation, United States, Puerto Rico, Australia, Taiwan, Israel, Spain, Canada, Greece, Argentina, Poland, Romania, Mexico, Slovakia, Brazil
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMalaysia, South Africa, Hong Kong, Taiwan, Philippines
-
Lexicon PharmaceuticalsCompletedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SRecruitingDiabetes, Type 2United States, India, Spain, Poland, South Africa, Bulgaria, Germany, Japan, Puerto Rico
-
InteKrin Therapeutics, Inc.CompletedType 2 Diabetes MellitusUnited States, Mexico
-
AstraZenecaQuintiles, Inc.CompletedType 2 DiabetesUnited States, Korea, Republic of, India, Russian Federation, Brazil, Mexico, South Africa, Philippines
-
MedImmune LLCCompleted
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2France, Poland, United Kingdom, United States, Spain, Colombia, India, Romania, South Africa, Ukraine, Australia, Canada, Greece, Sweden, New Zealand, Switzerland, Hong Kong
-
Yaounde Central HospitalUniversity of Exeter; University of Yaounde 1; MRC/UVRI & LSHTM Uganda Research...RecruitingType 1 Diabetes | Diabetes, AutoimmuneTanzania, Cameroon, South Africa, Uganda
-
Concert PharmaceuticalsCompletedType 2 Diabetes Mellitus | Chronic Kidney DiseaseUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMorocco, Tunisia, Algeria, South Africa, Egypt
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Thailand, Serbia, Poland, Hungary, Malaysia, South Africa, Ukraine, Czech Republic, Romania, Slovakia
-
Response PharmaceuticalsCompletedType 2 DiabetesUnited States
-
Konstantinos Makrilakis, MDUni-PharmaEnrolling by invitationDiabetes Mellitus, Type 2Greece
-
Harokopio UniversityCompletedDiabetes Mellitus, Type 2Greece
-
AstraZenecaCompletedType 2 DiabetesUnited States
-
Novo Nordisk A/SRecruitingType 2 Diabetes MellitusKorea, Republic of, United States, Serbia, Hungary, Spain, China, Australia, Finland, United Kingdom, Italy, Denmark, Canada, Taiwan, Germany, Sweden, South Africa, India, Poland, Argentina, Brazil, Bulgaria, Japan, Mexico, Turkey, Greece, Colomb... and more
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Korea, Republic of, Taiwan, Italy, Austria, Puerto Rico, Hungary, Greece, Poland, Spain, Romania, Ukraine, Argentina
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Lithuania, Netherlands, Puerto Rico, Romania, Slovakia, Sweden
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Serbia, Poland, Hungary, South Africa, Ukraine, Romania, Slovakia, Czech Republic
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Mexico, India
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
-
SanofiCompletedType 2 Diabetes MellitusEstonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain
-
Zafgen, Inc.TerminatedObesity | Type 2 DiabetesAustralia
-
TakedaTerminatedType 2 Diabetes MellitusUnited States, Poland, Ukraine, Taiwan, Bulgaria, Romania, Slovakia
-
AstraZenecaTerminatedType 2 Diabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Bahrain, Egypt, Jordan, Kuwait, Qatar, South Africa, United Arab Emirates
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada, Romania, Russian Federation, Ukraine, Germany, Spain, Philippines, Czech Republic, Mexico, Croatia, Chile, Morocco, South Africa, Australia, Venezuela
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Norway, Belgium, Hungary, Slovakia, Taiwan, Philippines, Thailand, Mexico, Hong Kong, Malaysia
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompletedStudy of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 DiabetesType 2 Diabetes MellitusKorea, Republic of, United States, Mexico, India, Puerto Rico, Russian Federation
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesUnited States, Peru, Mexico, Colombia, Costa Rica
-
SanofiCompletedType 2 Diabetes MellitusUnited States, South Africa, Canada, Czechia, Estonia, Finland, France, Germany, Hungary, Latvia, Mexico, Netherlands, Romania
-
TakedaCompletedDiabetes MellitusUnited States, Australia, Brazil, Guatemala, India, Mexico, New Zealand, Peru, South Africa, Czech Republic, Germany, Hungary, Netherlands, Argentina
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Brazil, Germany, Israel, Italy, United Kingdom, Australia, Hungary, Puerto Rico, Romania, Russian Federation, Spain, Poland, Canada, Greece, Turkey, Mexico, New Zealand, South Africa, Argentina, Finland, Lithuania, Sl...
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, South Africa, Canada
-
National Institute of Diabetes and Digestive and...University of North Carolina, Chapel HillCompleted
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesSweden, France, Italy, Mexico, South Africa, Spain, Germany, Netherlands, Argentina, United Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedDiabetes MellitusChina, United States, Canada, Mexico, Russian Federation, Croatia, United Kingdom, Argentina, Australia, India, South Africa, Greece, Ukraine, Romania, Italy, Hong Kong, Former Serbia and Montenegro, Brazil